GR60052B - Preparation process of anti-depressive compounds - Google Patents

Preparation process of anti-depressive compounds

Info

Publication number
GR60052B
GR60052B GR50333A GR760150333A GR60052B GR 60052 B GR60052 B GR 60052B GR 50333 A GR50333 A GR 50333A GR 760150333 A GR760150333 A GR 760150333A GR 60052 B GR60052 B GR 60052B
Authority
GR
Greece
Prior art keywords
preparation process
depressive
compounds
depressive compounds
preparation
Prior art date
Application number
GR50333A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of GR60052B publication Critical patent/GR60052B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
GR50333A 1975-03-20 1976-03-17 Preparation process of anti-depressive compounds GR60052B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
GR60052B true GR60052B (en) 1978-04-04

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
GR50333A GR60052B (en) 1975-03-20 1976-03-17 Preparation process of anti-depressive compounds

Country Status (27)

Country Link
US (1) US4085225A (el)
JP (1) JPS6026776B2 (el)
AR (2) AR211011A1 (el)
AT (1) AT340895B (el)
AU (1) AU505358B2 (el)
BE (1) BE839744A (el)
CA (1) CA1076142A (el)
CH (4) CH626057A5 (el)
DD (1) DD128332A5 (el)
DE (1) DE2610886A1 (el)
DK (1) DK144942C (el)
ES (1) ES446192A1 (el)
FI (1) FI61875C (el)
FR (1) FR2304336A1 (el)
GB (1) GB1535226A (el)
GR (1) GR60052B (el)
HU (1) HU171030B (el)
IE (1) IE43768B1 (el)
IL (1) IL49238A (el)
IT (1) IT1063064B (el)
MX (1) MX9203723A (el)
NL (1) NL7503310A (el)
PL (3) PL100052B1 (el)
SE (1) SE410312B (el)
SU (3) SU635867A3 (el)
YU (1) YU39345B (el)
ZA (1) ZA761434B (el)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
DE69607904T2 (de) * 1995-08-16 2000-10-05 Lilly Co Eli Potenzierung von Serotonin-Wirkstoffresponz
IN182588B (el) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (el) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
EP1276478A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
ES2666188T3 (es) * 2001-10-12 2018-05-03 Azevan Pharmaceuticals, Inc. Antagonistas del v1a de vasopresina beta-lactámicos
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
KR100828218B1 (ko) 2003-09-12 2008-05-07 화이자 인코포레이티드 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
ATE473967T1 (de) * 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006227199A1 (en) 2005-03-22 2006-09-28 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
CA2603900A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
CN101203216A (zh) * 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
WO2006116151A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
EP2317316A3 (en) 2005-07-08 2011-06-15 Braincells, Inc. Methods for identifying agent and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
US8048874B2 (en) * 2005-07-19 2011-11-01 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20070225279A1 (en) * 2006-03-24 2007-09-27 Wyeth Therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
WO2008086483A2 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5759470B2 (ja) 2009-10-23 2015-08-05 ヤンセン ファーマシューティカ エヌ．ベー． オレキシン受容体調節因子としての二置換オクタヒドロピロロ［３，４−ｃ］ピロール
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
RU2623209C9 (ru) 2010-07-01 2018-01-22 Азеван Фармасьютикалз, Инк. Способы лечения посттравматического стрессового расстройства
WO2012123922A1 (en) 2011-03-17 2012-09-20 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
EP2981518B1 (en) * 2013-04-03 2021-03-03 ZCL Chemicals Ltd. "an improved process for the preparation of fluvoxamine maleate"
CN106456578B (zh) 2014-02-07 2020-02-18 匈牙利科学院大学及其他机构附属研究所 Sigma-1受体激动剂化合物的用途
DK3122743T3 (da) 2014-03-28 2023-02-20 Azevan Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme
HRP20220642T1 (hr) * 2016-03-10 2022-06-24 Janssen Pharmaceutica Nv Postupci za liječenje depresije uporabom antagonista receptora oreksina 2
US20190335745A1 (en) 2016-11-24 2019-11-07 Sigmadrugs Kutató Korlátolt Felelösségü Társaság Compositions for organ preservation
CN111295373A (zh) 2017-09-15 2020-06-16 阿泽凡药物公司 用于治疗脑损伤的组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
CA1076142A (en) 1980-04-22
DE2610886A1 (de) 1976-10-07
IE43768L (en) 1976-09-20
IE43768B1 (en) 1981-05-20
BE839744A (fr) 1976-09-20
AT340895B (de) 1978-01-10
DK115976A (da) 1976-09-21
IT1063064B (it) 1985-02-11
ES446192A1 (es) 1977-10-01
US4085225A (en) 1978-04-18
CH626057A5 (el) 1981-10-30
SU620206A3 (ru) 1978-08-15
DE2610886C2 (el) 1987-09-24
DK144942B (da) 1982-07-12
CH629477A5 (de) 1982-04-30
SU635867A3 (ru) 1978-11-30
FI760699A (el) 1976-09-21
JPS51125345A (en) 1976-11-01
PL101951B1 (pl) 1979-02-28
PL100614B1 (pl) 1978-10-31
ATA195476A (de) 1977-05-15
SE410312B (sv) 1979-10-08
FI61875B (fi) 1982-06-30
IL49238A (en) 1978-08-31
MX9203723A (es) 1992-07-01
JPS6026776B2 (ja) 1985-06-25
SU645559A3 (ru) 1979-01-30
FR2304336B1 (el) 1979-09-28
CH629184A5 (de) 1982-04-15
AR211011A1 (es) 1977-10-14
DK144942C (da) 1982-12-06
NL7503310A (nl) 1976-09-22
YU39345B (en) 1984-10-31
AU505358B2 (en) 1979-11-15
GB1535226A (en) 1978-12-13
IL49238A0 (en) 1976-05-31
FR2304336A1 (fr) 1976-10-15
YU71476A (en) 1982-10-31
HU171030B (hu) 1977-10-28
AR211153A1 (es) 1977-10-31
SE7603341L (sv) 1976-09-21
FI61875C (fi) 1982-10-11
AU1214776A (en) 1977-09-22
ZA761434B (en) 1977-10-26
PL100052B1 (pl) 1978-08-31
DD128332A5 (de) 1977-11-09
CH629761A5 (de) 1982-05-14

Similar Documents

Publication Publication Date Title
GR60052B (en) Preparation process of anti-depressive compounds
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
GR60854B (en) Preparation process of benzylidenic derivatives
GR59797B (en) Preparation process of thieno-pyridine derivatives
PT65486A (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
GB1517423A (en) Process for the preparation of diaryl-carbonates
GR60835B (en) Preparation process of delta15-steroids
GR59482B (en) Preparation process of novel biphenyloxy-derivatives
GR60435B (en) Preparation process of acylamino-derivatives
GR60030B (en) Preparation process of new indolyl-alkylopiperidin
EG12413A (en) Process for preparing of 11-desoxy-16-aryloxy-pentanorprostaglandins
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
GR60849B (en) Preparation process of l-pyroglutamyl-l-prolinamide
EG12383A (en) Process for preparing of depot-steroidester
GR60822B (en) Preparation process of novel homophthalimides
GB1552658A (en) Process for the preparation of s substituted phosphorodichloridothiolates
JPS5233653A (en) Process for manufacture of nnalicyclic crbamate
PT65624B (en) Process of preparation of 4-hydroxymethyl-2-pyrrolidinones
PT65713B (en) Process for preparation of cycloalkanapyrazole with effectherbicide
GR61816B (en) Preparation process of novel antiferility compounds
JPS5278850A (en) Process for manufacture of 44chloroo22 butylmmchlorocarbanilate
JPS51125335A (en) Process for preparing orthooderivatives of paraaisopropenylphenol
GR60051B (en) Preparation process of anti-depressive compounds
ZA763221B (en) Process for the preparation of 3-bromobenzalidehyde